In the last trading session, 2.46 million shares of the OKYO Pharma Limited (NASDAQ:OKYO) were traded, and its beta was -0.29. Most recently the company’s share price was $1.85, and it changed around $0.01 or 0.54% from the last close, which brings the market valuation of the company to $62.70M. OKYO currently trades at a discount to its 52-week high of $1.98, offering almost -7.03% off that amount. The share price’s 52-week low was $0.81, which indicates that the current value has risen by an impressive 56.22% since then.

OKYO Pharma Limited stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended OKYO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

OKYO Pharma Limited (NASDAQ:OKYO) trade information

Instantly OKYO has showed a green trend with a performance of 0.54% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.9800 on recent trading dayincreased the stock’s daily price by 6.57%. The company’s shares are currently up 60.88% year-to-date, but still up 25.00% over the last five days. On the other hand, OKYO Pharma Limited (NASDAQ:OKYO) is 22.38% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -126.59%.

OKYO Dividends

OKYO Pharma Limited’s next quarterly earnings report is expected to be released in June.

The former held 12.09 shares worth $22366.0, making up 0.04% of all outstanding shares.